Phenotypic modulation from a contractile to a proliferative state within vascular smooth muscle cells has a critical role in the pathogenesis of a variety of cardiovascular diseases. To investigate the characterization of corpus cavernosum smooth muscle cell phenotype in diabetic rats with erectile dysfunction, a group of Sprague--Dawley rats (n ¼ 30) were induced by intraperitoneal injection of streptozotocin (60 mg kg ) and screened by subcutaneous injection of apomorphine (100 mg kg À1 ) for the measurement and comparison of the penile erections, and then three different groups were defined. Primary corpus cavernosum smooth muscle cells were cultured and passaged. The cavernous tissue segments were subjected to quantitative real-time polymerase chain reaction to determine the expressions of smooth muscle a-actin (SMA), SM myosin heavy chain (SMMHC), smoothelin, calponin and myocardin. Cell contractility in vitro and western blot analysis of SMA and SMMHC in the cavernous tissues and cells were determined. Compared with the control group (n ¼ 8) and the diabetes mellitus group (n ¼ 5), the expressions of SMA, calponin, SMMHC, smoothelin and myocardin mRNA were decreased in the cavernous tissues in rats of the diabetic erectile dysfunction group (n ¼ 15; P ¼ 0.001 and 0.02, P ¼ 0.014 and 0.012, both Po0.001, P ¼ 0.005 and o0.001, P ¼ 0.003 and 0.035, respectively). The levels of SMA and SMMHC proteins showed a significant decrease in cavernous tissues and cultured cells in rats of the diabetic erectile dysfunction group. Cells of the diabetic erectile dysfunction group exhibited significantly less contractility compared with those of other groups (Po0.001). Corpus cavernosum SM cell possesses the ability to modulate the phenotype under hyperglycemic conditions, which could have a key role in the pathogenesis of diabetic erectile dysfunction.
INTRODUCTION
Erectile dysfunction (ED), a distressing complication of diabetes mellitus (DM), 1 is three times more common in diabetic male rats than in non-diabetic male rats. It has been reported that about 35--90% of diabetic male rats suffer from ED. 2, 3 The pathogenesis of DM-related ED may be involved in many aspects; however, it was well known that vascular causative factors contribute significantly. 4 Corpus cavernosum smooth muscle (CCSM), the structural basis of cavernous space relaxing and penile erection, has a key role in the change of hemodynamics during penile erection. CCSM cell relaxation mediated by parasympathetic neurotransmission, nitric oxide, electrophysiological events and possibly other regulatory factors is necessary for normal penile erection. 5 It has been observed that the CCSM cell mass was lost in diabetic rats with ED, and the remaining SM cells were unable to achieve sufficient relaxation to attain the high intracorporeal pressures that are necessary for the passive occlusion of the veins that egress the corporal bodies as they traverse underneath and through the tunica albuginea of the penis. 6, 7 Therefore, the better understanding of CCSM cells may be useful to elucidate the pathophysiological process of diabetic ED.
In contrast to cardiac and skeletal muscle cells that have a terminally differentiated state, vascular SM cells can switch their phenotype from a contractile and differentiated state to a proliferative and dedifferentiated state in response to the change of local environmental stimuli. 8 This reversible transition is defined as phenotypic modulation characterized by enhanced proliferation, migration and expression of fibrotic and inflammatory proteins combined with decreased expression of contractilityassociated genes such as SM a-actin (SMA), SM myosin heavy chain (SMMHC), smoothelin, calponin and desmin. 9 It was well established that the phenotypic modulation within vascular SM cells has a critical role in the pathogenesis of a variety of cardiovascular diseases such as diabetic vascular complication, atherosclerosis, hypertension and transplantation arteriopathy. 8, 10 As the penis is considered as an extension of the vascular system, 11 it is not surprising to suppose that many changes of the cardiovascular system could also be found within the corporal tissue. However, to the best of our knowledge, the characteristics of the phenotypic modulation within CCSM cells under hyperglycemic conditions in diabetic rats were not well elucidated. Our previous study has demonstrated that the expression of SMA decreased in CCSM cells of diabetic rats with ED. 12 Considering more genes having recently been proposed to be contractilityassociated markers, we are prompted to further explore the possibility that phenotypic modulation of SM cells are involved in the development of diabetic ED. In this study, we investigated the expressions of SMA, calponin, SMMHC, smoothelin and myocardin at the mRNA levels in the cavernous tissues and the expressions of SMA and SMMHC at the protein levels in the cavernous tissues and cultured CCSM cells of diabetic rats. In addition, cell contractile competence was also measured.
MATERIALS AND METHODS

Establishment and grouping of a DM rat model
The protocols were approved by the Committee of Ethics on Animal Experimentation of Southern Medical University. In all, 30 adult male Sprague--Dawley rats (200--220 g and 8 weeks old) with normal erectile function were randomly divided into the control group (NDM, n ¼ 8) and streptozotocin-(Sigma, St Louis, MO, USA) treated group (n ¼ 22, including DM and ED group and DM group). To induce DM, 60 mg kg À1 streptozotocin was dissolved in citrate phosphate buffer composed of 0.1 M citric acid and 0.2 M disodium phosphate (pH 4.0), and then injected intraperitoneally. The rats in the control group were injected with an equal volume of buffer. DM was confirmed by measuring body weight and glucometer tail-vein blood glucose levels at the third day and then every 4 weeks after streptozotocin treatment. Rats with obviously lean body were considered to be diabetic when the blood glucose level was higher than 16.6 mmol l
À1
. 13 All rats were kept in a conventional temperaturecontrolled animal house with a 12 h light--dark cycle, and with continuous supply of food and water.
Penile erection experiment
Penile erection experiment was applied following the protocols described by other authors.
14 Lights were first turned down in a tranquil laboratory, and then we set rats in a transparent observation kit for about 10 min to make them acclimated to the new surroundings; thereafter, each rat was injected with 100 mg kg À1 apomorphine (Sigma) subcutaneously in the loose skin at the back of the neck. Each test rat was observed by two different people for 30 min after the injection, and the status and frequency of penile erection were recorded. Each glans engorgement and appearance of the penile shaft represents one erection. The number of erections in 30 min is taken as the erectile frequency. Erection rate refers to the ratio of the number of rats that showed erections to the total number of rats. Rats in the streptozotocin-treated group that did not show an erection in 30 min were included in the DM and ED group. 15 Cell culture and analysis To obtain pure CCSM cells, rat penile cavernous tissue explants (1--2 mm 3 ) were prepared as described previously. 16 Briefly, the fragments were washed aseptically and placed into culture flasks containing growth medium, the minimal volume of ice-cold Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum, 100 U ml À1 penicillin and 100 mg ml À1 streptomycin, and then incubated at 37 1C in a humidified atmosphere of 95% air and 5% CO 2 . It was usually the third day when CCSM cells began to migrate out from the explants; thus, the explants were removed from the culture flask the following day and cells were allowed to be confluent and then passaged. Cells from passage 2 of each group were harvested for immunocytochemistry. They were fixed in 4% paraformaldehyde and permeabilized in methanol; after blockade of nonspecific binding, cells were incubated with mouse monoclonal anti-SMA (1:100, ab7817; Abcam, Cambridge, UK). After overnight incubation, the cells were washed three times in phosphate-buffered saline and further incubated with the secondary antibody. For image analysis, five random fields per sample were photographed and recorded.
qRT-PCR analysis
Trizol reagent (Invitrogen, Carlsbad, CA, USA) was used according to the manufacturer's instructions to extract total RNA from the cavernous tissue segments, excluding the skin, head and corpus spongiosum of the penis. 
Western blot analysis
Western blot analysis of SMA or SMMHC was performed using the respective antibodies. In brief, samples containing 20 mg of total protein were drawn from cultured cells or tissues of each group, and were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and then transferred to nitrocellulose membrane. Transferred proteins were incubated with the mouse monoclonal anti-SMA (1:200; ab7817; Abcam) or anti-SMMHC antibody (1:300; ab97539; Abcam), and thereafter with horseradish peroxidase-conjugated secondary anti-mouse antibody (1:1500; Asbio Technology, Guangzhou, China). Protein expression was quantified by computer-assisted densitometry using the Gel Pro version 4.0 software. All specific blot values were corrected by b-actin expression.
Cell contractility assay
A modified collagen type I lattice contractility assay was used to determine the CCSM cell contractility in vitro. 17 Briefly, 2 Â 10 5 cells per ml SM cells from passage 2 in different groups were mixed with solubilized type I collagen (Shengyou Biotechnology, Hangzhou, China) to create a cell--collagen suspension at a final concentration of 1 mg ml
À1
. A 200 ml drop of the cell--collagen suspension was placed in a 35-mm culture dish, incubated in growth medium for the following 5 days and then the cell--collagen lattice was mechanically released from the underlying plastic substratum. Cells were exposed to Dulbecco's modified Eagle's medium plus 10% fetal bovine serum, serum-free Dulbecco's modified Eagle's medium medium or 1 mM calcium ionophore (A23187; Sigma). Lattice diameter changes at 10 min following the release were measured and quantified. Cell--collagen lattices released into the growth medium were used as a positive control, whereas those in the serum-deficient medium were used as a negative control. Contraction was calculated as the percent decrease in lattice diameter related to the diameter before stimulation.
Statistical analysis
All data were expressed as mean±s.d. Results were analyzed by one-way analysis of variance, and least significant difference or Dunnett's test (when equal variances were not assumed) was used for multiple comparisons. Statistical significance was considered when P-value was o0.05.
RESULTS
Animal model
As shown in Table 1 , the initial body weight and glucose level of all rats were checked, and no significant difference was found in the three groups (P ¼ 0.33 and 0.38, respectively). After 8 weeks, a significant weight loss (Po0.001) and remarkably increased glucose level (Po0.001) were observed in the streptozotocintreated group compared with the control group. Two rats with blood glucose levels o16.6 mmol l À1 after streptozotocin injection were excluded in the experiment. There was no difference in body weight and glucose level between the DM and ED group and DM group (P ¼ 0.707 and 0.95, respectively). The effect of DM on penile erection after 8 weeks is demonstrated in Table 2 . After apomorphine injection, rats in the streptozotocin-treated group exhibited less erectile frequency than the control group (Po0.001), and 15 rats in the streptozotocin-treated group did not show an erection in 30 min and were included in the DM and ED group.
Expressions of contractility-associated genes at the mRNA and protein levels We examined the expressions of contractility-associated genes at the mRNA level in the cavernous tissue from three groups by qRT-PCR. Compared with the control group and the DM group, the levels of SMA, calponin, SMMHC, smoothelin and myocardin were significantly decreased in rats in the DM and ED group (P ¼ 0.001 and 0.02, P ¼ 0.014 and 0.012, both Po0.001, P ¼ 0.005 and o0.001, P ¼ 0.003 and 0.035, respectively; Figure 1 ). Expressions of contractility-associated genes were downregulated in the DM group when compared with the control group; however, the difference did not show statistical significance (P40.05). To The data were expressed as the mean±s.d. (NDM group: n ¼ 8; DM group: n ¼ 5; DM and ED group: n ¼ 15). All results are representative of three independent experiments. *Po0.05, # Po0.001, compared with the DM and ED group. NDM, control group; DM, diabetes mellitus group; DM and ED, diabetic erectile dysfunction group.
confirm whether the decreased mRNA of contractility-associated genes was associated with a decrease at the protein level, western blot analysis was performed. In accordance with the expressions at the mRNA level, the levels of SMA and SMMHC at the protein level in the cavernous tissues were decreased in the rats of the DM and ED group (Figures 2a and b) .
To get a better understanding of the characterization of CCSM cells, we established and passaged primary cultures of cells from rat penile cavernous tissue fragments of three groups. We characterized the primary cultures by using specific immunocytochemical assays for SMA to establish the presence of SM cells. As shown in Figure 3a , positive fractions appeared completely among detected cells, which suggested that highly pure CCSM cells were used in the following experiments. No distinct morphological features were noted in the three types of cells. They had uniformly spindle-shaped morphology and a 'hill and valley' appearance in the confluent state (Figures 3b--d) .
Subsequently, the levels of SMA and SMMHC at the protein level in cultured CCSM cells were examined. We first found that when CCSM cells were placed in culture they gradually lost their SMA and SMMHC proteins (Figure 4) . Further, we chose CCSM cells from the steady early stage (the 2nd passage), and decreased expressions of SMA and SMMHC proteins were found in rats of the DM and ED group when compared with those of the other groups (Figures 5a and b) .
Cell contractility assay To confirm whether the contractile function of CCSM cells can be affected by the decreased levels of contractility-associated genes, the lattice contractility assay was performed. Consequently, CCSM cells of the DM and ED group exhibited significantly less contractility than those of other groups in response to 10% serum and growth factor calcium ionophore (Po0.001; Figure 6 ).
DISCUSSION
Phenotypic modulation, one of the most important characteristics within SM cells, has a critical role in the pathogenesis of a variety of diseases. Phenotypic modulation has recently been shown to occur within SM cells in cardiovascular system under abnormal conditions. CCSM cells are also important because of their central role in normal penile erection; however, little knowledge exists regarding the phenotypic modulation in rat CCSM cells. In this study, we provide evidence that CCSM cells have the ability to modulate the phenotype under hyperglycemic conditions, and that diabetic rats with ED tend to possess proliferative phenotype within CCSM cells.
Contractile and proliferative phenotypes represent two ends of a spectrum of SM cells with a continuum of states in between. 18 A variety of SM cell marker proteins, such as SMA, calponin, SMMHC, smoothelin, myocardin, h-caldesmon, telokin, metavinculin and desmin, were commonly used to define the SM cell phenotype. 8, 19 Many of these proteins are involved in SM cell contraction, either as a structural component of the contractile apparatus or as a regulator of contraction, and they are called contractility- associated markers. In contrast, as many of the other proteins, such as smemb and cell retinol binding protein-1, 20 are quickly and markedly upregulated in proliferating SM cells, they are used as proliferative SM cell markers. A shift in phenotype from a contractile to a proliferative state in theory leads to downregulated expression of contractility-associated markers and upregulated expression of proliferative SM cell markers. However, proliferative SM cell markers are rare and not widely used; instead, disappearance of contractility-associated markers is generally taken as characteristic of the proliferative phenotype. 21 Furthermore, SM cells with different phenotypes express different levels of the marker proteins rather than completely different marker proteins. 18 Therefore, at least two marker proteins that are associated with the contractile phenotype are used to distinguish a contractile SM cell from a proliferative SM cell in many current documents. 19, 21 In this study, we tested the expressions of five contractility-associated markers, including SMA, calponin, SMMHC, smoothelin and myocardin, and found that all of them were downregulated at the mRNA level in cavernous tissues of diabetic ED rats. Among these marker proteins, SMA is an excellent SM cell contractile marker, which is the first known protein expressed during differentiation of SM cells, 22 and is most widely used. In addition, SMMHC seems to be highly restricted to express in SM cells and is considered as the definitive SM cell marker. 23 Therefore, we chose these two important markers and determined their expression at protein levels. We demonstrated that the contractility-associated markers were downregulated in diabetic rats with ED, and that the cells from rats with ED exhibited significantly less contractility than the control group.
Burchardt et al. 6 reported a reduction of CCSM cells in a diabetic rat model compared with the control rat and aged rats by using computer-generated quantitative image analysis of immunohistochemical staining of the cells, and stated that the reduction is likely to be important in the loss of erectile function in diabetics. As many of these contractility-associated marker proteins are the structural component of SM cells, there is no doubt that their downregulated expressions in diabetic ED rats might also result from the reduction of SM cells in the cavernous tissues. To avoid any misleading in result interpretation, we used the in vitro system to obtain pure CCSM cells to ensure that equal quantity of sample protein concentrations from each group was analyzed in western blot analysis. Furthermore, in our experiment, we found that when CCSM cells were placed in culture they remained steady at early stages (only 1st and 2nd passage), and then gradually lost their contractility and developed features similar to those of proliferative SM cells. We compared the expressions of SMA and SMMHC at the protein levels in the early cultured CCSM cells (the 2nd passage) from different groups, and demonstrated the downregulated levels of SMA and SMMHC in diabetic ED rats. Taken together, even if cultured CCSM cells are biased toward a proliferative phenotype, which is an experimental limitation, significant difference in phenotype was clearly shown in the three groups. These results suggested that CCSM cells of diabetic ED rats tend to possess the proliferative phenotype. Our proposal contradicts a recent report by Zhang et al., 24 who studied the SM myosin expression, isoform composition and functional activities in rat corpus cavernosum altered by the streptozotocin-induced Type 1 diabetes and concluded that CCSM contractility was increased and switched to a more phasic contractile phenotype in the streptozotocin-induced Type 1 diabetic rats. This discrepancy might be attributed to the use of different isoforms of genes, as well as to the investigation of the different period of phenotype as contractile and proliferative SMCs, which represent the two ends of a spectrum of SMCs with intermediate phenotypes. Thus, these contradictory findings might actually reflect both the intrinsic SMC diversity and the diversity caused by a different local environment. To confirm a shift in phenotype, it is necessary to complement with data on morphological and functional characteristics. 25, 26 In this study, no distinct morphological features were noted in the cells from the three different groups, which is different from the findings in vascular SM cells. 18, 27 Herein, we suppose that cultured CCSM cells from diabetic ED rats have different functional characteristics with respect to cell contractility. Compared with other groups, CCSM cells from diabetic ED rats exhibited significantly less contractility in response to 10% serum and growth factor. With the information documented by other authors that the diabetic corporal tissue, in organ bath studies, relaxation responses to acetylcholine and the NO-donor sodium nitroprusside were severely lower than those of normal control, 11 we infer that altered intracellular contractile machinery is considered to be present in CCSM cells from diabetic ED rats, which might contribute to the changes observed in expression of contractilityassociated marker proteins.
Given that myocardin is a very important regulator in phenotypic modulation, 28 and in the downregulated expression in CCSM cells from diabetic ED rats found in this study, it will be very important to assess whether myocardin is also involved in phenotypic modulation of CCSM cells. In future studies, it will be exciting to determine the role of myocardin in modulating the phenotype of CCSM cells and maintaining erectile function in vivo.
A limitation of our work is that mating tests or cavernous nerve electrostimulation and intracorporal pressure measurement were not carried out in the protocol of identifying diabetic animals without ED. Heaton et al. 15 reported that apomorphine causes an observable erectile response in nearly 100% of normal rats; the appearance, in apomorphine erection experiment, of even a single apparently normal erection is enough to suggest that an animal is capable of erection and therefore could not be classified as impotent. However, the observation of penile tumescence in conscious rats may not be necessarily equated with normal erectile function, which is related to many molecular and functional changes in the corpus cavernosum. Mating studies and intracavernosal pressure recordings will be complementary to differentiate diabetic rats with ED from normal rats.
In summary, similar to other kinds of SM cells, CCSM cells possess the ability to modulate the phenotype from a contractile to a proliferative state under hyperglycemic conditions. These modulations could have a key role in the pathogenesis of diabetic ED. However, CCSM cells from the DM and NDM groups demonstrated identical responses in the contractility experiments, whereas CCSM cells from the DM and DM and ED groups, under the same hyperglycemic conditions, showed differences in contractile marker expression and contractility, which may be because SM cells in the DM groups have more intermediate status between contractile and proliferative phenotype; thus, the precise mechanisms need to be further studied.
